223 related articles for article (PubMed ID: 20404384)
1. Statins for primary prevention in older adults: who is high risk, who is old, and what denotes primary prevention?
Zieman SJ; Ouyang P
Ann Intern Med; 2010 Apr; 152(8):528-30, W183. PubMed ID: 20404384
[No Abstract] [Full Text] [Related]
2. [Statins in primary prophylaxis of cardiovascular diseases].
Kobalava ZhD; Villeval'de SV
Ter Arkh; 2011; 83(9):70-5. PubMed ID: 22145392
[TBL] [Abstract][Full Text] [Related]
3. Most would fail to benefit from JUPITER Intervention.
Plonk WM
J Am Coll Cardiol; 2009 Aug; 54(8):744; author reply 744-5. PubMed ID: 19679258
[No Abstract] [Full Text] [Related]
4. Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.
Prescrire Int; 2011 Apr; 20(115):94. PubMed ID: 21648210
[No Abstract] [Full Text] [Related]
5. Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.
Ann Intern Med; 2010 Apr; 152(8):I34. PubMed ID: 20404365
[No Abstract] [Full Text] [Related]
6. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].
Håkansson J
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433
[No Abstract] [Full Text] [Related]
7. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
[No Abstract] [Full Text] [Related]
8. [The JUPITER study emphasizes primary prevention].
Olsson AG
Lakartidningen; 2009 Jun 3-9; 106(23):1577. PubMed ID: 19583019
[No Abstract] [Full Text] [Related]
9. Was the FDA misled by JUPITER?
MacDonald GP
J Am Osteopath Assoc; 2010 Aug; 110(8):424-5. PubMed ID: 20805547
[No Abstract] [Full Text] [Related]
10. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Olsson AG
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
[No Abstract] [Full Text] [Related]
11. Study stirs debate about statin use in those without high cholesterol.
Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535
[No Abstract] [Full Text] [Related]
12. [JUPITER--think first, act subsequently!].
Linnersten L
Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1758. PubMed ID: 19731744
[No Abstract] [Full Text] [Related]
13. [The JUPITER study poses more questions than answers].
Håkansson J
Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1757. PubMed ID: 19731743
[No Abstract] [Full Text] [Related]
14. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
Duvernoy CS; Blumenthal R
Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
[No Abstract] [Full Text] [Related]
15. Rosuvastatin in patients undergoing hemodialysis.
de Oliveira JM
N Engl J Med; 2009 Jul; 361(1):93-4; author reply 94-5. PubMed ID: 19579278
[No Abstract] [Full Text] [Related]
16. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
17. The Jupiter trial--new territory for statins?
Wheeler DC
Nephrol Dial Transplant; 2009 Jul; 24(7):2036-7. PubMed ID: 19541666
[No Abstract] [Full Text] [Related]
18. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
Albert MA; Glynn RJ; Fonseca FA; Lorenzatti AJ; Ferdinand KC; MacFadyen JG; Ridker PM
Am Heart J; 2011 Jul; 162(1):106-14.e2. PubMed ID: 21742096
[TBL] [Abstract][Full Text] [Related]
19. Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".
Wells MT; Eisenberg T
Circulation; 2010 Dec; 122(23):e575; author reply e577. PubMed ID: 21135368
[No Abstract] [Full Text] [Related]
20. Sunset for statins after AURORA?
Strippoli GF; Craig JC
N Engl J Med; 2009 Apr; 360(14):1455-7. PubMed ID: 19332454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
